Adhoc: Sandoz Group AG: Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access
Sandoz Group AG / Key word(s): Regulatory Approval Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access 29-Jul-2026 / 11:30 CET/C…
